findmyKOL
Clinical trialNCT01513759CompletedPhase 3Interventional

Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy

SponsorBoston Scientific CorporationEnrollment150Acute Pulmonary EmbolismMassive Pulmonary EmbolismPulmonary EmbolismPulmonary ThromboembolismSub-massive Pulmonary Embolism
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine if the EKOS EkoSonic® Endovascular Device when used in conjunction with recombinant tissue plasminogen activator (t-PA) as a treatment for acute PE will decrease the ratio of right ventricle (RV) to left ventricle (LV) diameter within 48 =/- 6 hours in participants with massive or submassive PE.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Baptist Health

    Montgomery, Alabama, United States

  • Memorial Medical Center

    Modesto, California, United States

  • Stanford University Medical Center

    Stanford, California, United States

  • Hartford Hospital

    Hartford, Connecticut, United States

  • Christiana Hospital

    Newark, Delaware, United States

  • Lakeland Regional Medical Center

    Lakeland, Florida, United States

  • Holmes Regional Medical Center

    Melbourne, Florida, United States

  • Florida Hospital

    Orlando, Florida, United States

  • Orlando Regional Medical Center

    Orlando, Florida, United States

  • Medical Center of Central Georgia

    Macon, Georgia, United States

  • Prairie Heart Institute

    Springfield, Illinois, United States

  • St. Vincent Hospital

    Indianapolis, Indiana, United States

  • University of Kentucky, Gill Heart Institute

    Lexington, Kentucky, United States

  • East Jefferson General Hospital

    New Orleans, Louisiana, United States

  • Hackensack University Medical Center

    Hackensack, New Jersey, United States

  • Overlook Medical Center

    Morristown, New Jersey, United States

  • Holy Name Hospital

    Teaneck, New Jersey, United States

  • Montefiore Medical Center

    The Bronx, New York, United States

  • Mt. Carmel East

    Columbus, Ohio, United States

  • the Miriam Hospital

    Providence, Rhode Island, United States

  • Providence Memorial and Sierra Medical Center

    El Paso, Texas, United States

  • Inova Alexandria Hospital

    Alexandria, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
7 Jun 2012
Primary completion
17 Feb 2013
Completion
17 Feb 2013
Last update posted
19 Jul 2021
Registered enrollment
150
Registry id
NCT01513759

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.